 | • レポートコード：GIR-107A12211 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、糖尿病検査室用イムノアッセイのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病検査室用イムノアッセイの種類別市場規模（血液検査、ブドウ糖負荷試験、糖化ヘモグロビン測定、インスリン分析、Cペプチド分析、その他）、用途別市場規模（病院、クリニック、研究センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・糖尿病検査室用イムノアッセイの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer AG、Jei Daniel Biotech Corp.、Becton Dickenson、Acon Laboratories Inc.、Beckman Coulter Inc.、Immunoshop India Pvt Ltd.、Institute Of Isotopes Co. Ltd、Instrumentation Laboratory Co.、Abbott Diagnostics、Qqlab Llc、Quidel Corp.、Radiometer Gmbh、Roche Diagnostics Corp.、Siemens Healthcare、Sysmex、Novartis Vaccines & Diagnostics Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血液検査、ブドウ糖負荷試験、糖化ヘモグロビン測定、インスリン分析、Cペプチド分析、その他 ・用途別分析2016年-2026年：病院、クリニック、研究センター ・糖尿病検査室用イムノアッセイの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・糖尿病検査室用イムノアッセイのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・糖尿病検査室用イムノアッセイのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・糖尿病検査室用イムノアッセイの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・糖尿病検査室用イムノアッセイの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Diabetes Laboratory Immunoassays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Diabetes Laboratory Immunoassays size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Diabetes Laboratory Immunoassays market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Diabetes Laboratory Immunoassays market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Blood Test
Glucose Tolerance Test
Glycated Hemoglobin Determination
Insulin Assay
C Peptide Assay
Other
Market segment by Application, can be divided into
Hospital
Clinic
Research Center
Market segment by players, this report covers
Bayer AG
Jei Daniel Biotech Corp.
Becton Dickenson
Acon Laboratories Inc.
Beckman Coulter Inc.
Immunoshop India Pvt Ltd.
Institute Of Isotopes Co. Ltd
Instrumentation Laboratory Co.
Abbott Diagnostics
Qqlab Llc
Quidel Corp.
Radiometer Gmbh
Roche Diagnostics Corp.
Siemens Healthcare
Sysmex
Novartis Vaccines & Diagnostics Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Diabetes Laboratory Immunoassays product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Diabetes Laboratory Immunoassays, with revenue, gross margin and global market share of Diabetes Laboratory Immunoassays from 2019 to 2021.
Chapter 3, the Diabetes Laboratory Immunoassays competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Diabetes Laboratory Immunoassays market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Diabetes Laboratory Immunoassays research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Diabetes Laboratory Immunoassays
1.2 Classification of Diabetes Laboratory Immunoassays by Type
1.2.1 Overview: Global Diabetes Laboratory Immunoassays Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Diabetes Laboratory Immunoassays Revenue Market Share by Type in 2020
1.2.3 Blood Test
1.2.4 Glucose Tolerance Test
1.2.5 Glycated Hemoglobin Determination
1.2.6 Insulin Assay
1.2.7 C Peptide Assay
1.2.8 Other
1.3 Global Diabetes Laboratory Immunoassays Market by Application
1.3.1 Overview: Global Diabetes Laboratory Immunoassays Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Diabetes Laboratory Immunoassays Market Size & Forecast
1.5 Global Diabetes Laboratory Immunoassays Market Size and Forecast by Region
1.5.1 Global Diabetes Laboratory Immunoassays Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Diabetes Laboratory Immunoassays Market Size by Region, (2016-2021)
1.5.3 North America Diabetes Laboratory Immunoassays Market Size and Prospect (2016-2026)
1.5.4 Europe Diabetes Laboratory Immunoassays Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Diabetes Laboratory Immunoassays Market Size and Prospect (2016-2026)
1.5.6 South America Diabetes Laboratory Immunoassays Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Diabetes Laboratory Immunoassays Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Laboratory Immunoassays Market Drivers
1.6.2 Diabetes Laboratory Immunoassays Market Restraints
1.6.3 Diabetes Laboratory Immunoassays Trends Analysis
2 Company Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Diabetes Laboratory Immunoassays Product and Solutions
2.1.4 Bayer AG Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer AG Recent Developments and Future Plans
2.2 Jei Daniel Biotech Corp.
2.2.1 Jei Daniel Biotech Corp. Details
2.2.2 Jei Daniel Biotech Corp. Major Business
2.2.3 Jei Daniel Biotech Corp. Diabetes Laboratory Immunoassays Product and Solutions
2.2.4 Jei Daniel Biotech Corp. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Jei Daniel Biotech Corp. Recent Developments and Future Plans
2.3 Becton Dickenson
2.3.1 Becton Dickenson Details
2.3.2 Becton Dickenson Major Business
2.3.3 Becton Dickenson Diabetes Laboratory Immunoassays Product and Solutions
2.3.4 Becton Dickenson Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Becton Dickenson Recent Developments and Future Plans
2.4 Acon Laboratories Inc.
2.4.1 Acon Laboratories Inc. Details
2.4.2 Acon Laboratories Inc. Major Business
2.4.3 Acon Laboratories Inc. Diabetes Laboratory Immunoassays Product and Solutions
2.4.4 Acon Laboratories Inc. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Acon Laboratories Inc. Recent Developments and Future Plans
2.5 Beckman Coulter Inc.
2.5.1 Beckman Coulter Inc. Details
2.5.2 Beckman Coulter Inc. Major Business
2.5.3 Beckman Coulter Inc. Diabetes Laboratory Immunoassays Product and Solutions
2.5.4 Beckman Coulter Inc. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Beckman Coulter Inc. Recent Developments and Future Plans
2.6 Immunoshop India Pvt Ltd.
2.6.1 Immunoshop India Pvt Ltd. Details
2.6.2 Immunoshop India Pvt Ltd. Major Business
2.6.3 Immunoshop India Pvt Ltd. Diabetes Laboratory Immunoassays Product and Solutions
2.6.4 Immunoshop India Pvt Ltd. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Immunoshop India Pvt Ltd. Recent Developments and Future Plans
2.7 Institute Of Isotopes Co. Ltd
2.7.1 Institute Of Isotopes Co. Ltd Details
2.7.2 Institute Of Isotopes Co. Ltd Major Business
2.7.3 Institute Of Isotopes Co. Ltd Diabetes Laboratory Immunoassays Product and Solutions
2.7.4 Institute Of Isotopes Co. Ltd Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Institute Of Isotopes Co. Ltd Recent Developments and Future Plans
2.8 Instrumentation Laboratory Co.
2.8.1 Instrumentation Laboratory Co. Details
2.8.2 Instrumentation Laboratory Co. Major Business
2.8.3 Instrumentation Laboratory Co. Diabetes Laboratory Immunoassays Product and Solutions
2.8.4 Instrumentation Laboratory Co. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Instrumentation Laboratory Co. Recent Developments and Future Plans
2.9 Abbott Diagnostics
2.9.1 Abbott Diagnostics Details
2.9.2 Abbott Diagnostics Major Business
2.9.3 Abbott Diagnostics Diabetes Laboratory Immunoassays Product and Solutions
2.9.4 Abbott Diagnostics Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Abbott Diagnostics Recent Developments and Future Plans
2.10 Qqlab Llc
2.10.1 Qqlab Llc Details
2.10.2 Qqlab Llc Major Business
2.10.3 Qqlab Llc Diabetes Laboratory Immunoassays Product and Solutions
2.10.4 Qqlab Llc Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Qqlab Llc Recent Developments and Future Plans
2.11 Quidel Corp.
2.11.1 Quidel Corp. Details
2.11.2 Quidel Corp. Major Business
2.11.3 Quidel Corp. Diabetes Laboratory Immunoassays Product and Solutions
2.11.4 Quidel Corp. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Quidel Corp. Recent Developments and Future Plans
2.12 Radiometer Gmbh
2.12.1 Radiometer Gmbh Details
2.12.2 Radiometer Gmbh Major Business
2.12.3 Radiometer Gmbh Diabetes Laboratory Immunoassays Product and Solutions
2.12.4 Radiometer Gmbh Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Radiometer Gmbh Recent Developments and Future Plans
2.13 Roche Diagnostics Corp.
2.13.1 Roche Diagnostics Corp. Details
2.13.2 Roche Diagnostics Corp. Major Business
2.13.3 Roche Diagnostics Corp. Diabetes Laboratory Immunoassays Product and Solutions
2.13.4 Roche Diagnostics Corp. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Roche Diagnostics Corp. Recent Developments and Future Plans
2.14 Siemens Healthcare
2.14.1 Siemens Healthcare Details
2.14.2 Siemens Healthcare Major Business
2.14.3 Siemens Healthcare Diabetes Laboratory Immunoassays Product and Solutions
2.14.4 Siemens Healthcare Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Siemens Healthcare Recent Developments and Future Plans
2.15 Sysmex
2.15.1 Sysmex Details
2.15.2 Sysmex Major Business
2.15.3 Sysmex Diabetes Laboratory Immunoassays Product and Solutions
2.15.4 Sysmex Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Sysmex Recent Developments and Future Plans
2.16 Novartis Vaccines & Diagnostics Inc.
2.16.1 Novartis Vaccines & Diagnostics Inc. Details
2.16.2 Novartis Vaccines & Diagnostics Inc. Major Business
2.16.3 Novartis Vaccines & Diagnostics Inc. Diabetes Laboratory Immunoassays Product and Solutions
2.16.4 Novartis Vaccines & Diagnostics Inc. Diabetes Laboratory Immunoassays Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Novartis Vaccines & Diagnostics Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diabetes Laboratory Immunoassays Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Diabetes Laboratory Immunoassays Players Market Share
3.2.2 Top 10 Diabetes Laboratory Immunoassays Players Market Share
3.2.3 Market Competition Trend
3.3 Diabetes Laboratory Immunoassays Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diabetes Laboratory Immunoassays Revenue and Market Share by Type (2016-2021)
4.2 Global Diabetes Laboratory Immunoassays Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Diabetes Laboratory Immunoassays Revenue Market Share by Application (2016-2021)
5.2 Diabetes Laboratory Immunoassays Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Diabetes Laboratory Immunoassays Revenue by Type (2016-2026)
6.2 North America Diabetes Laboratory Immunoassays Revenue by Application (2016-2026)
6.3 North America Diabetes Laboratory Immunoassays Market Size by Country
6.3.1 North America Diabetes Laboratory Immunoassays Revenue by Country (2016-2026)
6.3.2 United States Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
6.3.3 Canada Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
6.3.4 Mexico Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Diabetes Laboratory Immunoassays Revenue by Type (2016-2026)
7.2 Europe Diabetes Laboratory Immunoassays Revenue by Application (2016-2026)
7.3 Europe Diabetes Laboratory Immunoassays Market Size by Country
7.3.1 Europe Diabetes Laboratory Immunoassays Revenue by Country (2016-2026)
7.3.2 Germany Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
7.3.3 France Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
7.3.5 Russia Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
7.3.6 Italy Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Type (2016-2026)
8.2 Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Application (2016-2026)
8.3 Asia-Pacific Diabetes Laboratory Immunoassays Market Size by Region
8.3.1 Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Region (2016-2026)
8.3.2 China Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
8.3.3 Japan Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
8.3.4 South Korea Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
8.3.5 India Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
8.3.7 Australia Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Diabetes Laboratory Immunoassays Revenue by Type (2016-2026)
9.2 South America Diabetes Laboratory Immunoassays Revenue by Application (2016-2026)
9.3 South America Diabetes Laboratory Immunoassays Market Size by Country
9.3.1 South America Diabetes Laboratory Immunoassays Revenue by Country (2016-2026)
9.3.2 Brazil Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
9.3.3 Argentina Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Type (2016-2026)
10.2 Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Application (2016-2026)
10.3 Middle East & Africa Diabetes Laboratory Immunoassays Market Size by Country
10.3.1 Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Country (2016-2026)
10.3.2 Turkey Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
10.3.4 UAE Diabetes Laboratory Immunoassays Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Diabetes Laboratory Immunoassays Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Diabetes Laboratory Immunoassays Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Diabetes Laboratory Immunoassays Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Diabetes Laboratory Immunoassays Revenue (USD Million) by Region (2016-2021)
Table 5. Global Diabetes Laboratory Immunoassays Revenue Market Share by Region (2021-2026)
Table 6. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 7. Bayer AG Major Business
Table 8. Bayer AG Diabetes Laboratory Immunoassays Product and Solutions
Table 9. Bayer AG Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Jei Daniel Biotech Corp. Corporate Information, Head Office, and Major Competitors
Table 11. Jei Daniel Biotech Corp. Major Business
Table 12. Jei Daniel Biotech Corp. Diabetes Laboratory Immunoassays Product and Solutions
Table 13. Jei Daniel Biotech Corp. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Becton Dickenson Corporate Information, Head Office, and Major Competitors
Table 15. Becton Dickenson Major Business
Table 16. Becton Dickenson Diabetes Laboratory Immunoassays Product and Solutions
Table 17. Becton Dickenson Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Acon Laboratories Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Acon Laboratories Inc. Major Business
Table 20. Acon Laboratories Inc. Diabetes Laboratory Immunoassays Product and Solutions
Table 21. Acon Laboratories Inc. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Beckman Coulter Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Beckman Coulter Inc. Major Business
Table 24. Beckman Coulter Inc. Diabetes Laboratory Immunoassays Product and Solutions
Table 25. Beckman Coulter Inc. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Immunoshop India Pvt Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Immunoshop India Pvt Ltd. Major Business
Table 28. Immunoshop India Pvt Ltd. Diabetes Laboratory Immunoassays Product and Solutions
Table 29. Immunoshop India Pvt Ltd. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Institute Of Isotopes Co. Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Institute Of Isotopes Co. Ltd Major Business
Table 32. Institute Of Isotopes Co. Ltd Diabetes Laboratory Immunoassays Product and Solutions
Table 33. Institute Of Isotopes Co. Ltd Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Instrumentation Laboratory Co. Corporate Information, Head Office, and Major Competitors
Table 35. Instrumentation Laboratory Co. Major Business
Table 36. Instrumentation Laboratory Co. Diabetes Laboratory Immunoassays Product and Solutions
Table 37. Instrumentation Laboratory Co. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Abbott Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. Abbott Diagnostics Major Business
Table 40. Abbott Diagnostics Diabetes Laboratory Immunoassays Product and Solutions
Table 41. Abbott Diagnostics Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Qqlab Llc Corporate Information, Head Office, and Major Competitors
Table 43. Qqlab Llc Major Business
Table 44. Qqlab Llc Diabetes Laboratory Immunoassays Product and Solutions
Table 45. Qqlab Llc Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Quidel Corp. Corporate Information, Head Office, and Major Competitors
Table 47. Quidel Corp. Major Business
Table 48. Quidel Corp. Diabetes Laboratory Immunoassays Product and Solutions
Table 49. Quidel Corp. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Radiometer Gmbh Corporate Information, Head Office, and Major Competitors
Table 51. Radiometer Gmbh Major Business
Table 52. Radiometer Gmbh Diabetes Laboratory Immunoassays Product and Solutions
Table 53. Radiometer Gmbh Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Roche Diagnostics Corp. Corporate Information, Head Office, and Major Competitors
Table 55. Roche Diagnostics Corp. Major Business
Table 56. Roche Diagnostics Corp. Diabetes Laboratory Immunoassays Product and Solutions
Table 57. Roche Diagnostics Corp. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 59. Siemens Healthcare Major Business
Table 60. Siemens Healthcare Diabetes Laboratory Immunoassays Product and Solutions
Table 61. Siemens Healthcare Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Sysmex Corporate Information, Head Office, and Major Competitors
Table 63. Sysmex Major Business
Table 64. Sysmex Diabetes Laboratory Immunoassays Product and Solutions
Table 65. Sysmex Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Novartis Vaccines & Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 67. Novartis Vaccines & Diagnostics Inc. Major Business
Table 68. Novartis Vaccines & Diagnostics Inc. Diabetes Laboratory Immunoassays Product and Solutions
Table 69. Novartis Vaccines & Diagnostics Inc. Diabetes Laboratory Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Diabetes Laboratory Immunoassays Revenue (USD Million) by Players (2019-2021)
Table 71. Global Diabetes Laboratory Immunoassays Revenue Share by Players (2019-2021)
Table 72. Breakdown of Diabetes Laboratory Immunoassays by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Diabetes Laboratory Immunoassays Players Head Office, Products and Services Provided
Table 74. Diabetes Laboratory Immunoassays Mergers & Acquisitions in the Past Five Years
Table 75. Diabetes Laboratory Immunoassays New Entrants and Expansion Plans
Table 76. Global Diabetes Laboratory Immunoassays Revenue (USD Million) by Type (2016-2021)
Table 77. Global Diabetes Laboratory Immunoassays Revenue Share by Type (2016-2021)
Table 78. Global Diabetes Laboratory Immunoassays Revenue Forecast by Type (2021-2026)
Table 79. Global Diabetes Laboratory Immunoassays Revenue by Application (2016-2021)
Table 80. Global Diabetes Laboratory Immunoassays Revenue Forecast by Application (2021-2026)
Table 81. North America Diabetes Laboratory Immunoassays Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Diabetes Laboratory Immunoassays Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Diabetes Laboratory Immunoassays Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Diabetes Laboratory Immunoassays Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Diabetes Laboratory Immunoassays Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Diabetes Laboratory Immunoassays Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Diabetes Laboratory Immunoassays Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Diabetes Laboratory Immunoassays Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Diabetes Laboratory Immunoassays Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Diabetes Laboratory Immunoassays Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Diabetes Laboratory Immunoassays Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Diabetes Laboratory Immunoassays Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Diabetes Laboratory Immunoassays Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Diabetes Laboratory Immunoassays Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Diabetes Laboratory Immunoassays Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Diabetes Laboratory Immunoassays Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Diabetes Laboratory Immunoassays Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Diabetes Laboratory Immunoassays Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Diabetes Laboratory Immunoassays Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Diabetes Laboratory Immunoassays Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Diabetes Laboratory Immunoassays Picture
Figure 2. Global Diabetes Laboratory Immunoassays Revenue Market Share by Type in 2020
Figure 3. Blood Test
Figure 4. Glucose Tolerance Test
Figure 5. Glycated Hemoglobin Determination
Figure 6. Insulin Assay
Figure 7. C Peptide Assay
Figure 8. Other
Figure 9. Diabetes Laboratory Immunoassays Revenue Market Share by Application in 2020
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Research Center Picture
Figure 13. Global Diabetes Laboratory Immunoassays Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Diabetes Laboratory Immunoassays Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Diabetes Laboratory Immunoassays Revenue Market Share by Region (2016-2026)
Figure 16. Global Diabetes Laboratory Immunoassays Revenue Market Share by Region in 2020
Figure 17. North America Diabetes Laboratory Immunoassays Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Diabetes Laboratory Immunoassays Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Diabetes Laboratory Immunoassays Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Diabetes Laboratory Immunoassays Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Diabetes Laboratory Immunoassays Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Diabetes Laboratory Immunoassays Market Drivers
Figure 23. Diabetes Laboratory Immunoassays Market Restraints
Figure 24. Diabetes Laboratory Immunoassays Market Trends
Figure 25. Bayer AG Recent Developments and Future Plans
Figure 26. Jei Daniel Biotech Corp. Recent Developments and Future Plans
Figure 27. Becton Dickenson Recent Developments and Future Plans
Figure 28. Acon Laboratories Inc. Recent Developments and Future Plans
Figure 29. Beckman Coulter Inc. Recent Developments and Future Plans
Figure 30. Immunoshop India Pvt Ltd. Recent Developments and Future Plans
Figure 31. Institute Of Isotopes Co. Ltd Recent Developments and Future Plans
Figure 32. Instrumentation Laboratory Co. Recent Developments and Future Plans
Figure 33. Abbott Diagnostics Recent Developments and Future Plans
Figure 34. Qqlab Llc Recent Developments and Future Plans
Figure 35. Quidel Corp. Recent Developments and Future Plans
Figure 36. Radiometer Gmbh Recent Developments and Future Plans
Figure 37. Roche Diagnostics Corp. Recent Developments and Future Plans
Figure 38. Siemens Healthcare Recent Developments and Future Plans
Figure 39. Sysmex Recent Developments and Future Plans
Figure 40. Novartis Vaccines & Diagnostics Inc. Recent Developments and Future Plans
Figure 41. Global Diabetes Laboratory Immunoassays Revenue Share by Players in 2020
Figure 42. Diabetes Laboratory Immunoassays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Diabetes Laboratory Immunoassays Revenue Market Share in 2020
Figure 44. Global Top 10 Players Diabetes Laboratory Immunoassays Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Diabetes Laboratory Immunoassays Revenue Share by Type in 2020
Figure 47. Global Diabetes Laboratory Immunoassays Market Share Forecast by Type (2021-2026)
Figure 48. Global Diabetes Laboratory Immunoassays Revenue Share by Application in 2020
Figure 49. Global Diabetes Laboratory Immunoassays Market Share Forecast by Application (2021-2026)
Figure 50. North America Diabetes Laboratory Immunoassays Sales Market Share by Type (2016-2026)
Figure 51. North America Diabetes Laboratory Immunoassays Sales Market Share by Application (2016-2026)
Figure 52. North America Diabetes Laboratory Immunoassays Revenue Market Share by Country (2016-2026)
Figure 53. United States Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Diabetes Laboratory Immunoassays Sales Market Share by Type (2016-2026)
Figure 57. Europe Diabetes Laboratory Immunoassays Sales Market Share by Application (2016-2026)
Figure 58. Europe Diabetes Laboratory Immunoassays Revenue Market Share by Country (2016-2026)
Figure 59. Germany Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Diabetes Laboratory Immunoassays Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Diabetes Laboratory Immunoassays Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Diabetes Laboratory Immunoassays Revenue Market Share by Region (2016-2026)
Figure 67. China Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Diabetes Laboratory Immunoassays Sales Market Share by Type (2016-2026)
Figure 74. South America Diabetes Laboratory Immunoassays Sales Market Share by Application (2016-2026)
Figure 75. South America Diabetes Laboratory Immunoassays Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Diabetes Laboratory Immunoassays Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Diabetes Laboratory Immunoassays Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Diabetes Laboratory Immunoassays Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Diabetes Laboratory Immunoassays Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界の糖尿病用インスリンデリバリーペン市場 2021：企業別、地域別、種類・用途別 The Diabetes Insulin Delivery Pens market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の糖尿病治療市場 2021：企業別、地域別、種類・用途別 The Diabetes Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の糖尿病治療・ドラッグデリバリー市場 2021：企業別、地域別、種類・用途別 The Diabetes Therapy and Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の糖尿病デバイス市場 2021：企業別、地域別、種類・用途別 The Diabetes Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の糖尿病用ペン市場 2021：企業別、地域別、種類・用途別 The Diabetes Pens market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…